glp 1 cardiovascular disease and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia GLP-1 medicines may cut clot-related

27,36 In a controlled study, 63 patients with type 2 diabetes and a lower-extremity ulcer were randomized to either saxagliptin 5 mg or placebo daily

With the comparator treatment, nine events occurred in 5,863 PYOs

Willow at a Glance: Cost, Medications, and Telehealth Model 3

The cardiovascular outcomes suggest that GLP-1 therapy offers systemic health benefits beyond simple calorie restriction, making these medications attractive for overall metabolic health even in the absence of diabetes

GLP-1 Drugs and Testosterone: What the Review Found Scientists at the University Hospitals Coventry and Warwickshire and Warwick Medical School in the United Kingdom searched medical databases for published randomized controlled trials assessing the reproductive effects of GLP-1 medications in adult men ages 18 to 65